| Literature DB >> 32682783 |
Bin Wang1, Yanfang Liang2, Xingxing Chai3, Shasha Chen4, Ziyu Ye5, Ronggang Li6, Xiaoping Li7, Gang Kong8, Yanyun Li9, Xueying Zhang10, Zhengping Che11, Yongke You12, Shicai Ye13, Lili Li14, Bihua Lin15, Juan Huang16, Mingyuan Huang17, Xin Zhang18, Xianxiu Qiu19, Jincheng Zeng20.
Abstract
Colorectal cancer is the second leading cause of cancer mortality worldwide with poor prognosis and high recurrence. Aberrant Wnt/β-catenin signaling promotes oncogenesis by transcriptional activation of c-Myc and its downstream signals. EDAR is characterized as an important effector of canonical Wnt signaling in developing skin appendages, but the interplay between EDAR and Wnt signaling in tumorigenesis and progression remains to be elucidated. In this study, we revealed that EDAR expression is prevalently elevated in colorectal cancer tissues compared with normal tissues. Further analysis suggests there is a strict correlation between EDAR expression and colorectal cancer progression. EDAR silencing by shRNA in colorectal cancer cells showed proliferative suppression via retarding cell cycle at G1 phase. Xenograft mice transplanted with shEDAR-transduced tumor cells significantly alleviated tumor burden in comparison with control mice. Furthermore, downregulation of EDAR was accompanied by reduction of β-catenin, c-Myc and other G1 cell cycle regulators, while β-catenin agonist restored the expression of these proteins and overrode the proliferative block induced by EDAR knockdown. These findings indicate that EDAR functions as a component of Wnt/β-catenin signaling pathway, and is a potential modulator in colorectal carcinogenesis.Entities:
Keywords: Cell proliferation; Colorectal cancer; EDAR; Wnt/β-catenin signaling pathway
Year: 2020 PMID: 32682783 DOI: 10.1016/j.yexcr.2020.112170
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905